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Research Article
IRRITABILITY IN CHILD AND ADOLESCENT
ANXIETY DISORDERS
Joel Stoddard, M.D., MAS,1∗ Argyris Stringaris, M.D., Ph.D.,2 Melissa A. Brotman, Ph.D.,1
Daniel Montville, B.S.,1 Daniel S. Pine, M.D.,3 and Ellen Leibenluft, M.D.1
Background: Our objective was to compare self- and parent-reported irritability
in youths with anxiety disorders, healthy youths, and those with mood disorders
characterized by irritability. Irritability is a common but relatively understudied
psychiatric symptom in child and adolescent anxiety disorders. In anxious youths,
little is known about the severity of irritability, its impact on functioning, or
the effect of informant source on reports of irritability. Methods: We compared
parent- and self-report forms of the Affective Reactivity Index (ARI), a vali-
dated measure of irritability, in youths ages 8–17 years with no psychopathology
(healthy comparison, HC; n = 38), anxiety disorders (ANX; n = 42), bipolar
disorder (BD; n = 35), or severe mood dysregulation (SMD; n = 61; a phenotype
characterized by chronic, severely impairing irritability). Results: Irritability
was significantly higher in ANX than HC youths by both parent and self-report
(partial η2 = 0.24 and 0.22, respectively, P’s< 0.001). Informant effects differed
among ANX, BD, and SMD. Overall, parent-reported irritability was higher in
BD with comorbid anxiety disorders and SMD with or without comorbid anxiety
disorders than ANX (P’s < 0.007), but self-reported irritability was not signifi-
cantly different among the three patient groups.Discussion: By both parent and
self-report, youths with anxiety disorders exhibit significantly more irritabil-
ity and associated impairment than healthy subjects. Self-reported irritability in
youths with anxiety disorders is comparable to that observed in youths with severe
mood disorders, although parental reports of irritability differ among the disor-
ders. Future research should examine the pathophysiology of anxiety-associated
irritability, as well as its prognostic and treatment implications. Depression and
Anxiety 00:1–8, 2013. C© 2013 Wiley Periodicals, Inc.
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INTRODUCTION
Irritability is deﬁned as a tendency toward negative af-
fective states, usually anger, coupled with a propensity to
exhibit temper outbursts.[1–3] It is a symptom or associ-
ated feature of several anxiety disorders in DSM-IV.[4,5]
Studies suggest that clinically signiﬁcant irritability is
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endorsed commonly in youths with anxiety disorders,
particularly for generalized anxiety disorder, where irri-
tability is a criterion for the condition.[6–9] For example,
in the largest of these, 65% of 650 youths presenting
for treatment with any DSM-IV anxiety disorder were
judged to have clinically signiﬁcant irritability.[6] These
studies assessed the presence or absence of irritability
in child and adolescent anxiety disorders using a single
item from an omnibusmeasure of anxiety symptoms, the
Anxiety Disorders Interview Schedule for Children and
Parents.[10] Consequently, though these data suggest
that irritability is often endorsed in treatment-seeking
anxious youths, remarkably little else is known about this
symptom through systematic research.
Twoproperties of irritability in anxious youths are rel-
evant to bothdiagnosis and treatment planning: its sever-
ity and its impact on functioning. Therefore, as a ﬁrst
step, it is important to compare the degree of irritability
and associated impairment in youths with anxiety dis-
orders to those without psychopathology (healthy com-
parison group; HC); to our knowledge, no prior work
documents this comparison. In addition, because multi-
ple informants should be considered in the assessment
of child psychopathology,[11] it is important to ascertain
whether informant source affects reports of irritability in
the context of anxiety or other disorders. Here, we ad-
dress these questions by (1) comparing parent and self-
reports of irritability and associated impairment among
youths with anxiety versus healthy subjects, and (2) com-
paring severity of irritability as well as informant effects
in youths with anxiety versus thosewith severemood dis-
orders characterized by irritability, i.e., bipolar disorder
(BD) and severemood dysregulation (SMD). SMD is not
aDSM-IVdeﬁneddisorder but is a psychiatric syndrome
in children deﬁned for research purposes and character-
ized by severe, impairing, nonepisodic irritability.[12,13]
In addition to the few studies of irritability in
treatment-seeking anxious children noted above, several
other lines of evidence suggest links between irritability
and child and adolescent anxiety disorders. First, a lim-
ited epidemiological literature links irritability to youth
anxiety in the general population.[14,15] Second, adults
with anxiety disorders, who typically also manifest anxi-
ety as children,[16] exhibit more irritability than healthy
comparison subjects.[2] Finally, high levels of irritability
during childhood predict elevated risk for anxiety and
depressive disorders in adulthood.[17,18]
Thus, we used the Affective Reactivity Index (ARI)
to measure the severity of irritability and its associ-
ated impairment in youths with anxiety disorders be-
cause it is a validated, dimensional measure of irritability
and contains an item that assesses irritability-associated
impairment.[3] First, we compared levels of irritabil-
ity and its associated impairment in treatment-seeking
youths with anxiety disorders versus healthy subjects. In
a secondary analysis, we compared irritability in youths
with anxiety disorders to irritability in youths with SMD
or BD. Given the controversy about the diagnosis of
BD in irritable children,[12] several studies on irritability
in clinical samples compare youths with SMD to those
with BD. In the present study, both groups serve as
benchmarks of clinically signiﬁcant irritability. Youths
with SMD are selected for clinically signiﬁcant, im-
pairing irritability.[13] Recent work has shown that they
have highest levels of ARI-measured irritability rela-
tive to several clinical and nonclinical groups.[3] While
those with BD are not selected for chronic irritability,
prior work has shown they also have abnormally high
levels of ARI-measured irritability,[3] which is consis-
tent with clinical observations of abnormal irritability
in child and adolescent BD.[19] Furthermore, when as-
sessing irritability in clinical populations, clinicians, and
researchers should consider both parent and self-report,
because parent and self-report of behavioral and emo-
tional symptoms often differ in both general and clini-
cal populations.[20] We hypothesized that we would ﬁnd
higher levels of parent- or self-reported irritability and
more irritability-associated impairment in patients with
anxiety disorders than in healthy controls. Consistent
with this hypothesis, we also expected to ﬁnd an associ-
ation between anxiety symptom severity and irritability.
In an exploratory, secondary analysis, we tested for dif-
fering levels of both parent and self-reported irritability
and its associated impairment among patients with anx-
iety disorders, SMD, and BD.
METHOD
PARTICIPANTS
The primary analyses included youths with anxiety disorders (ANX;
n = 42; ages 8–17 years) and those without psychopathology (healthy
comparison group; HC; n = 38; ages 8–17 years; Table 1). ANX and
HC participants were self or clinician referred and recruited through
advertisement primarily from the Washington, D.C. metropolitan
area. Data from these groups were gathered between 2010 and 2012.
Psychiatric diagnoses were made by master’s- or doctoral-level clin-
icians trained to reliability (κ>0.7) using the Schedule for Affective
Disorders and Schizophrenia for School-Age Children-Present and
Lifetime Version (KSADS-PL)[21] and conﬁrmed with a senior psy-
chiatrist. Those in the anxiety disorder group met criteria for gen-
eralized anxiety disorder (GAD), separation anxiety disorder (SAD),
and/or social phobia (SoPh). Other inclusion criteria for patients
were clinically important anxiety on the Pediatric Anxiety Rating
Scale (score≥10),[22] impairment on the Children’s Global Assess-
ment Scale (score<60),[23] and desire for weekly treatment. To ex-
cludemood disorder-related irritability, patients with a history of bipo-
lar I, bipolar II, or major depressive disorder were excluded. Other
exclusion criteria for anxiety patients were current Tourette’s syn-
drome, obsessive-compulsive disorder, posttraumatic stress disorder,
conduct disorder, or suicidal ideation. These exclusion criteria related
to the main goal of the anxiety-disorder research program, which
examines pathophysiology. Pathophysiology of these excluded con-
ditions is thought to differ from that in the included anxiety dis-
orders. For similar reasons, participants were excluded for lifetime
history of exposure to extreme trauma, psychosis, and autism spec-
trum disorder. Healthy volunteers were included if they were free of
any KSADS-PL diagnoses. Exclusion criteria for both patients and
healthy volunteers were history of severe trauma, chronic or active
medical condition, psychoactive substance use within last 2 months,
history of head trauma, current psychotropic medication use, and
Depression and Anxiety
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TABLE 1. Participant characteristics
HCa ANX SMD BD Test statistic P
n = 38 n = 42 n = 61 n = 35
Sex
% female 39.5% 57.1% 36.1% 48.6% χ2 = 5.10 0.165
Age (years)
Mean (SD) 13.5 (2.3) 10.9 (2.4) 12.6 (2.3) 15.2 (2.3) F(3,172) = 23.1 <0.001b
IQ
Mean (SD) 116.5 (12.3) 109.3 (13.9) 106.9 (13.8) 103.7 (15.6) F(3,172) = 5.8 0.001c
SESd
Mean (SD) 38.2 (17.5) 34.2 (13.2) 40.8 (19.8) 43.6 (19.9) F(3,141) = 1.6 0.200
Race/Ethnicitye n (%) χ2 P
Hispanic/Latino 0 6 (14%) 1 (2%) 1 (3%) 12.2 0.007
Asian 0 2 (5%) 4 (7%) 0 4.8 0.188
Black/African American 3 (8%) 3 (7%) 0 2 (6%) 4.5 0.212
White 31 (82%) 25 (60%) 49 (83%) 31 (89%) 11.9 0.008
Other 4 (11%) 6 (14%) 5 (9%) 1 (3%) 3.1 0.376
KSADS diagnoses n (%) χ2 P
Any anxiety n/a 30 (49%) 26 (74%) 5.8 0.016f
SAD 20 (48%) 14 (23%) 12 (34%) 6.8 0.033
GAD 29 (69%) 22 (36%) 21 (60%) 12.0 0.002
SoPh 24 (57%) 13 (21%) 10 (29%) 14.8 0.001
ADHD 4 (10%) 51 (84%) 29 (83%) 66.8 <0.001
ODD 1 (2%) 44 (72%) 13 (37%) 50.1 <0.001
aHC, healthy control; ANX, anxiety disorders; SMD, severe mood dysregulation; BD, bipolar disorder.
bPost hoc comparisons showed that ANX<SMD<BD, ANX<HC = BD, and HC = SMD.
cPost hoc comparisons showed that BD = SMD<HC and ANX = All.
dSES refers to socioeconomic status measured by the Hollingshead 2 factor index.[31] SES data were not available for 31 participants.
eSelf-identiﬁed race/ethnicity categories and labels are consistent with current U.S. federal guidelines.[32] Hispanic/Latino is deﬁned as an ethnicity
that may be of any race, others are divided by racial categories presented. No participant identiﬁed as Native Hawaiian/Other Paciﬁc Islander or
American Indian/Alaskan Native. “Other” refers to participants who identiﬁed as two or more races or other. Race/ethnicity data were not available
for two individuals in the SMD group.
fProportions of “any anxiety” were tested between the BD and SMD groups only, all other KSADS diagnoses were tested between ANX, BD, and
SMD groups.
gHigh rates of ADHD and ODD are expected in the SMD and BD groups because of their characteristic irritability.
FSIQ < 70. Intelligence was measured using the Wechsler Abbre-
viated Scale of Intelligence (WASI).[24]
ARI data from 61 youths with severe mood dysregulation (SMD)
and 35 youths with bipolar disorder (BD) were included in the sec-
ondary analysis, along with data from the 42 anxious youths. Ages
ranged from 8–17 years in all groups. The selection process, partic-
ipant description, and ARI data for youths with BD and SMD were
reported previously.[3] Brieﬂy, self or clinician referred SMD and BD
participants were recruited nationally via advertisement. Their travel
and lodging was arranged for them. Reliable (κ>0.9) masters or doc-
toral level clinicians administered a KSADS-PL that was modiﬁed to
detect SMD, and ﬁnal diagnoses were assigned in a consensus confer-
ence chaired by a senior psychiatrist. Data used in this study from the
SMD and BD groups were gathered between 2010 and 2012.
BD patients met full DSM-IV criteria[4] for BD I or II, including
a history of at least one episode lasting ≥4 days for hypomania, ≥7
days for mania, and including euphoria and/or grandiosity.[13] SMD
patients had abnormal baseline mood (anger or sadness), hyper re-
activity to negative emotional stimuli (e.g., explosive, developmen-
tally inappropriate outbursts at least 3 times/week), and hyperarousal
(≥3 of insomnia, intrusiveness, pressured speech, ﬂight of ideas/racing
thoughts, distractibility, psychomotor agitation).[13] SMD symptoms
must begin before age 12, occur for≥1 year without remission exceed-
ing 2 months, and cause functional impairment in 2 settings. Patients
with a history of euphoric mood or distinct (hypo)manic episodes last-
ing >1 day, or 6-month history of major depressive disorder, were
excluded from the SMD group. The exclusion criteria for the SMD
and BD groups were the same as for the anxiety disorders group except
that the following were not exclusionary for SMD or BD: current psy-
chotropic medication use, suicidal ideation, Tourette’s disorder, and
obsessive-compulsive disorder.
The study was approved by the NIMH Institutional Review Board.
Written informed consent was obtained from parents and assent from
children. Families were paid for participation.
MEASURES
TheAffectiveReactivity Index (ARI) is a parent- and self-ratedmea-
sure validated for youths ages 6–17 years. It has excellent internal con-
sistencies in several clinical and nonclinical groups (α’s>0.88) and is
adequately described by a one-factor solution in conﬁrmatory factor
analyses.[3] It contains six items speciﬁc for irritability, such as whether
the youth is “is easily annoyed by others,” “gets angry frequently,” or
"often loses his/her temper.”[3] Items are rated on a three-level re-
sponse scale (“not true,” “somewhat true,” and “certainly true,” scored
0, 1, and 2, respectively). The total score is the sum of these six items,
resulting in a possible score of 0–12, which we treated as a continuous
measure. The ARI also contains one, general impairment item rated
on the same three-level scale. The item asks the respondent whether
irritability has caused them problems overall. We treated responses
on this item as an ordinal measure of impairment due to irritability
Depression and Anxiety
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and therefore used nonparametric tests (Mann–Whitney U, Kruskal–
Wallis, and Spearman tests) whenever involving impairment. Respon-
dents are prompted to consider their feelings and behavior for the
prior 6 months. Parent and child forms are identical except for the
substitution of “you” for “your child” in the child versus the parent
form.
The Screen for Child Anxiety Related Disorders (SCARED) is a
parent- and self-rated measure validated for those 8 and older.[25] It
contains 41 items probing symptoms of anxiety disorders for 3 months
prior to assessment. The items are rated on a three-level scale analo-
gous to the ARI. We used total scores, which range from 0–82, as a
continuous measure of anxiety disorder symptom severity.
ANALYSES
All analyses were performed using SPSS, version 21 (IBM, Armonk,
NY). Our primary analysis tested differences between self- and parent-
rated ARI total scores in the HC and ANX groups. The secondary
analysis tested differences in irritability amongmental disorders (ANX,
SMD, and BD) and by informant. Age and IQ may inﬂuence both the
degree of irritability and its reporting. Since these variables differed
among groups (Table 1), they were entered as covariates in all analy-
ses, except in the nonparametric tests of impairment. Another concern
is that sex may inﬂuence reporting of irritability. Because sex ratios did
not differ between the groups, we report here analyses without sex as a
covariate. However, since ANX had the highest proportion of females,
additional analyses, not presented, conﬁrmed that the addition of sex as
a covariate did not change the ﬁndings presented here. Further, there
were differences in self-identiﬁcation as White or Hispanic/Latino in
theANXgroup relative to the other groups (Table 1).However, within
the anxiety group, there were no differences in parent- or self-report
total ARI score or impairment by White or Hispanic/Latino identiﬁ-
cation using t or Mann–Whitney U tests (all P’s > 0.19). Effect sizes
were measured using partial η2. In behavioural science, η2 of 0.01,
0.06, and 0.14 may be considered the boundaries for small, medium,
and large effects.[26] Probability values were adjusted with Bonferroni
correction for all tests involving multiple comparisons.
For the primary analysis, we tested whether ARI measures of irri-
tability differed between patients with anxiety disorders and healthy
subjects. In two analyses, we used univariate ANCOVA, in which the
dependent variablewas either total parent- or self-report ARI score and
the predicting factor had two levels: HC and ANX. ANCOVA results
were adjusted for unequal variance with the Brown–Forsythe method
because the HC group total ARI score distributions had narrow dis-
persions and ﬂoor effects, with half of both parent- and self-report
ARIs totaling zero. The corrected ANCOVA accommodated the dis-
tribution of the HC group while allowing us to covary for age and IQ.
Within the ANX group, we used Pearson’s correlations to assess asso-
ciations between the severity of anxiety symptoms (SCARED scores)
and irritability (total ARI scores).
In three separate regression analyses, each of which included avail-
able data from the ANX and HC groups, we tested the relationship
between speciﬁc anxiety disorders (i.e., SAD, GAD, and SoPh) and
parent-reported irritability, self-reported irritability, or the mean of
parent- and self-reported irritability.Meanof parent- and self-reported
irritability was used to approximate the clinical practice of considering
both youth andparent reportwhendetermining thepresence of psychi-
atric symptoms.[11] These three regression models each included the
same independent variables: GAD (present or absent), SAD (present
or absent), SoPh (present or absent), age (years), and intelligence (IQ).
The three models differed by their dependent variable, which was self-
reported total ARI score, parent-reported total ARI score, or the mean
of parent and self-reported total ARI score.
In addition, we compared impairment due to irritability with a
Mann–Whitney U test. In the ANX group, we used Pearson’s cor-
Figure 1. Average total ARI scores by reporter for the diagnostic
groupings used in the analyses. Error bars represent the standard
error of the mean. A “±ANX” denotes the presence of a comor-
bid anxiety disorder that defines the ANX group, SAD, SoPH,
or GAD. For the analysis of irritability in mental disorders (sec-
ondary analysis), the numbers in each bar represent the sample
size for each group in the which both parent and self-report are
present for each individual.
relations to assess associations between parent- and self-reported total
ARI andSCAREDscores.Within theANXgroup,weusedSpearman’s
correlations to assess associations between anxiety symptom severity
(SCARED scores) and impairment due to irritability (responses to the
ARI impairment item).
For the secondary analysis, we used a repeated measures ANCOVA
to compare irritability in ANX, SMD, and BD, focusing on the effects
of mental disorder and informant. This approach allows us to test the
effects of informant on irritability and is valid because each member
of the parent–child dyad reports on the child’s behavior.[27] The de-
pendent variable was total ARI score, the within subjects factor was
informant with two levels, parent- and self-report. We also examined
the impact of comorbid anxiety on irritability in the context of SMD
andBD.To do so, we divided the SMDandBDgroups by the presence
or absence of anxiety disorder. Therefore, the between subjects factor,
disorder, had ﬁve levels: ANX, SMD with comorbid anxiety disorders
(SAD, GAD, or SoPh; SMD+ANX), SMD without comorbid anxiety
disorders (SMD-ANX), BD without comorbid ANX (BD-ANX), and
BD with comorbid ANX (BD+ANX). Thirty-ﬁve of 42 in the ANX
group, 57 of 61 in the SMD group, and 34 of 35 in the BD group
had both parent- and self-report forms available and were included in
this analysis. The seven excluded individuals in the ANX group did
not differ from the others in total ARI scores, age, sex, or intelligence.
Finally, we used Kruskall–Wallis and post hocMann–Whitney U tests
to compare the ﬁve groups (i.e., ANX, SMD±ANX, and BD±ANX)
on impairment due to irritability.
RESULTS
IRRITABILITY IN YOUTHS WITH ANXIETY
DISORDERS VERSUS HEALTHY SUBJECTS
Parent report of irritability was greater for ANX than
HC (mean (SD) total ARI score: ANX = 3.4 (2.9),
HC = 0.49 (1.0); F(1,52.4) = 14.2, P < 0.001; Fig. 1).
Likewise, self-report of irritability was greater for ANX
than for HC (mean (SD) total ARI score: ANX = 3.9
(2.8), HC = 0.89 (1.4); F(1,64.3) = 14.6, P < 0.001;
Fig. 1). The magnitude of the effect for the HC-ANX
Depression and Anxiety
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TABLE 2. The relationship between specific anxiety
disorders and irritability
Model ﬁts
Modela n Adjusted R2 F P
Self-report 79 0.18 3.89 0.002
Parent-Report 71 0.30 6.05 <0.001
Mean 70 0.39 8.46 <0.001
Parameter estimatesb
Disordera Model b SE P
GAD Self-report 1.72 0.70 0.017
Parent-report 0.96 0.66 0.149
Mean 1.39 0.53 0.011
SoPh Self-report 0.80 0.67 0.237
Parent-report 2.14 0.63 0.001
Mean 1.40 0.51 0.008
SAD Self-report 0.24 0.80 0.765
Parent-report 1.51 0.76 0.051
Mean 1.31 0.61 0.034
aAll regression models include the independent variables generalized
anxiety disorder (GAD), Social phobia (SoPh), and separation anxiety
disorder (SAD), age and IQ. Age and IQwere not signiﬁcant predictors
in any model. Models differ by their dependent variable: self-report
total ARI score, parent-report total ARI score, and average of parent
and self-report total ARI score.
bSince disorders are entered into the model as “present or absent,”
parameter estimates (b) may be interpreted as the average increase in
total ARI score associated with that disorder.
comparison was similarly large for both parent and self-
report (partial η2 = 0.24 and 0.22, respectively). In re-
gression analyses including all three diagnoses (Table 2),
GADbutneither SoPHnorSADpredicted self-reported
irritability (b= 1.72,P= 0.017) while SoPh and SADbut
not GAD predicted parent-reported irritability (SoPh:
b = 2.14, P = 0.001 and SAD: b = 1.51, P = 0.051). All
three diagnoses predicted the mean of parent- and self-
reported irritability (GAD: b = 1.39, P = 0.011; SoPh:
b = 1.40, P = 0.008; SAD: b = 1.31, P = 0.034).
In the HC group, all 35 parents and 35 of 38 youths
rated the item asking whether irritability causes prob-
lems as “not true.”However, in the ANX group, 18 of 36
parents and 19 of 41 youths rated this item as “somewhat
true” or “certainly true.” These reporting patterns differ
between the HC and ANX groups for parent-reported
impairment (U = 315, P < 0.001) and self-reported im-
pairment (U = 469, P < 0.001).Within the ANX group,
mean ARI score was associated with the level of reported
impairment. For parent report, mean total ARI signiﬁ-
cantly increases byparent impairment rating: 1.7 for “not
true,” 4.3 for “somewhat true,” and 7.0 for “certainly
true” (F(2,33) = 13.9, P < 0.001). For self-report, there
is a similar pattern: 2.5 for “not true,” 5.0 for “some-
what true,” and 6.3 for “certainly true” (F(2,38) = 9.0,
P < 0.001).
In patients with anxiety disorders, there was a sig-
niﬁcant correlation between self-report ARI and self-
report SCARED total scores (r = 0.32, P = 0.045), but
not between parent reports of these measures (r = 0.13,
P = 0.45). There was a signiﬁcant correlation between
self-reported impairment due to irritability and self-
report SCARED total scores (ρ = 0.36, P = 0.021), but
not between parent reports of these measures (ρ = 0.15,
P = 0.37).
IRRITABILITY IN EMOTIONAL DISORDERS:
EFFECT OF DISORDER AND INFORMANT
In predicting ARI score, there was an interaction be-
tween informant (i.e., parent or self-report), anddisorder
(F(4,119) = 5.54, P ≤ 0.001, partial η2 = 0.157; Fig. 1).
This interaction was driven by lower parent report of
irritability in the ANX group than in the BD+ANX and
SMD±ANXgroups (P’s≤ 0.002), while self-report of ir-
ritability did not differ among the ﬁve diagnostic groups.
Considering this interaction another way, parent versus
self-report differed in the BD+ANX and SMD±ANX
groups (P’s≤0.007,with parent report beinghigher than
self-report) but not in the BD-ANX or ANX groups.
Within the BDor SMDgroups, neither parent- nor self-
reported irritability differed between those with comor-
bid anxiety and those without comorbid anxiety disor-
ders (P’s ≥ 0.237, uncorrected for multiple comparisons
to facilitate the detection of a difference).
There was also a main effect of disorder (F(4,119) =
8.99, P < 0.001, partial η2 = 0.232; Fig. 1), with higher
scores in the SMD±ANXgroups than in theANXgroup
(P’s < 0.001). The main effect of informant was non-
signiﬁcant (P = 0.387; partial η2 = 0.006).
Impairment due to irritability differed among ANX,
BD±ANX, and SMD±ANX by both parent report
(Kruskal–Wallis χ2 = 40.06, P < 0.001) and self-report
(Kruskal–Wallis χ2 = 9.61, P = 0.048). Parent-reported
impairment was lower in ANX than in SMD±ANX,
and lower in ANX than in BD+ANX (P’s < 0.004).
Self-reported impairment was rated lower in ANX than
SMD+ANX (P = 0.032).
DISCUSSION
We compared parent- and self-reported irritability
and its associated impairment in treatment-seeking
youths with anxiety disorders, ﬁrst to healthy subjects
and then to youths with severe mood disorders charac-
terized by irritability. We expected to ﬁnd higher levels
of irritability and its associated impairment in those with
anxiety disorders relative to healthy subjects, and to ﬁnd
different patterns of parent and self-reported irritability
between anxiety and mood disorders. Our results
support both of these hypotheses. Relative to youths
without psychopathology, both parent and self-report
of irritability was high for youths with anxiety disorders.
However, relative to their parents’ ratings, youths
with severe mood disorders rated their own irritability
lower, whereas youths with anxiety disorders and their
parents did not differ in their assessment of the child’s
irritability.
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Our ﬁnding of markedly greater irritability in youths
with anxiety disorders relative to healthy youths is
consistent with the limited available data from epi-
demiologic, adult psychopathological, and personality
studies. Clinical researchers have observed that clinically
signiﬁcant irritability is commonly present in child and
adolescent anxiety disorders.[6–9] We conﬁrmed this
observation with a valid measure of irritability, the ARI,
applied independently of diagnostic assessment of anx-
iety disorder. The degree of ARI-measured irritability
in youths with anxiety disorders is likely clinically sig-
niﬁcant, given its large effect size versus healthy youths,
its association with impairment, and its similarity to the
degree of irritability in mood disorders characterized by
irritability. Given the correlations that we observed be-
tween ARI and SCARED scores, highly anxious youths
may be particularly likely to exhibit irritability. Clearly,
clinicians should determine whether youths with anx-
iety disorders are experiencing impairing irritability.
Conversely, to the extent that irritability is frequently a
presenting complaint for youths with anxiety disorders,
clinicians and researchers may need to assess irritable
youths for the presence of anxiety disorders.
Concerning treatment planning, irritability may be
an important target symptom for both pharmacologic
and psychosocial intervention, as about half of anxious
youths and their parents identiﬁed irritability as a prob-
lematic symptom. Moreover, a number of anxious indi-
viduals had irritability ratings that were as high as irri-
tability ratings in the SMD group, a group deﬁned by
clinically signiﬁcant and impairing irritability. Of note,
serotonergic antidepressants are often indicated for the
treatment of pediatric anxiety, but such treatment may
be withheld if the child is misdiagnosed as having bipo-
lar disorder on the basis of severe irritability, even in the
absence of manic episodes.[12] Therefore, careful diag-
nostic assessment is essential in this setting.
We found that GAD, SoPh, and SAD were each asso-
ciated with increased self- or parent-reported irritabil-
ity and that all three diagnoses were associated with the
combined report of irritability from the two informants.
When both parent and self-report are considered, the
association of similar levels of irritability with all three
anxiety disorders suggests that irritability is not uniquely
associated with any one of them. This ﬁnding is con-
sistent with a recent large study (n = 650) that found
that the presence of clinically signiﬁcant irritability is (1)
prevalent in 65% of youths who have at least one DSM-
IV anxiety disorder and (2) has a low speciﬁcity (0.49)
for GAD relative to other anxiety disorders.[6] Thus, ev-
idence does not suggest that, among child and adolescent
anxiety disorders, GAD is uniquely associated with irri-
tability.
By parent report only, irritability was greater in both
groups with mood disorders than in youths with anxiety
disorders. Those with SMDwere selected based on par-
ent reports of irritability, so high parent-reported ARI
scores are expected in this group. However, there was no
speciﬁc selection for irritability in bipolar youths, who
were screened instead for a history of discrete manic
episodes; nonetheless, parent report of irritability was
higher in the group with bipolar and comorbid anxiety
disorders than in the group with anxiety disorders only.
Despite these differences in parent-reported irritabil-
ity, mean self-reported irritability was similar among
patients with anxiety or mood disorders. That is, the
informant effect of higher parent- than self-reported
irritability was present in SMD patients, with or without
comorbid anxiety, and in BD patients with comorbid
anxiety, but not in patients with anxiety disorders
alone. Speculatively, these data may reﬂect impairments
youths with SMD and BD have in their ability to
label emotions. Indeed, children with SMD and medi-
cated BD have deﬁcits labeling emotional prosody,[28]
and youths with SMD or BD are more impaired in
face-emotion labeling than both healthy subjects and
those with anxiety disorders.[29] It is possible that the
deﬁcit that youths with SMD exhibit in labeling the
emotions of others may extend to self-monitoring,
and therefore self-reporting, of mood. However, this
suggestion remains speculative because we did not
assess face-emotion labeling ability in the subjects in
this study. It is also possible that the higher mean parent
than self-report of irritability in SMD and BD but not
in ANX is due to between group differences in parental
mood, personality, or other characteristics. However,
it is important to note that the inclusion criteria for
SMD require the presence of irritability outside the
home, as documented by collateral information such as
school records of accommodations, disciplinary action,
etc.
This study has some pertinent limitations. First, we
are limited by the use of parent and self-report to mea-
sure irritability. There are a number of characteristics
of parents, youths, and symptoms themselves that may
inﬂuence the report of any symptom in pediatric anxiety
disorders.[11,30] For example, social desirability bias may
result in under-reporting by both parents and youths.
This might be most salient in the case of anxious youths,
who are acutely aware of others’ evaluations of them.[11]
More negative affect in parents of youths with anxi-
ety disorders relative to other groups might affect their
ratings of their children’s irritability.[11] Parent and self-
reports of irritability may be related to other traits, such
as neuroticism and negative affectivity, that we did not
measure in our patient groups.[1] While we cannot ac-
count for such sources of reporter bias in our sample,
our results are consistent with the prior literature.
Second, we excluded subjects with a history of major
depressive disorder from the anxiety disorders group.
In fact, no depressive disorders of any sort were present
in the anxiety disorders group, with the exception of
one participant who had an adjustment disorder with
depressed mood. Therefore, we could not meaningfully
examine associations between depressive symptoms and
irritability in subjects with anxiety disorders; future
research should focus on this. Third, our inability to
detect differences in comparisons involving the patients
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with bipolar disorder but without anxiety disorders may
be due to small sample size (n = 8). Fourth, in analyses
that included theHC group as well as affected youth, the
distribution of ARI scores in the HC group did not
allow us to test for an interaction between informant
and the presence of an anxiety disorder. Fifth, the
impairment measure was limited to a single item on
the ARI, coadministered with the irritability items. As
such, the measure of impairment was not speciﬁc to
any domain. Thus, the impairment ﬁndings require
replication, preferably with an independent, more
comprehensive measure. Finally, the ARI is simple and
brief and not designed as an in-depth assessment of the
phenomenology of irritability.
In summary, we found high levels of irritability and its
associated impairment in child and adolescent anxiety
disorders, reported by both parents and youths them-
selves. Irritability between anxiety and mood disorders
differed by parent report but not by self-report. Future
research should focus on the clinical signiﬁcance of irri-
tability within anxiety disorders, especially as a predictor
of course and outcomes.
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